Figure S4 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors — Ismael A. Vergara (2025) | RDL Network
Figure S4 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors
Article 2025 en
Authors
IV
Ismael A. Vergara
NM
Nigel Maher
AP
Alison J. Potter
Abstract
1 min read
<p>Boxplot of scores from the bivariate genomic model in discovery and validation. The optimal cut-off that maximises the difference between true positive rate (TPR) and false positive rate (FPR) corresponding to the Youden index is identified at 0.65. Red line indicates the optimal cut-off.</p>
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Discussion(0)
No comments yet. Be the first to comment.